C4 Therapeutics, Inc.
CCCCNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $389.48M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.69$5.17
- Volume (live)
- -
- Avg. volume (3M)
- 2.53M
C4 Therapeutics (CCCC) Stock Price & Financial Analysis
C4 Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.94 - $3.07 |
|---|---|
| 52-Week High | $5.17 |
| 52-Week Low | $1.69 |
| Open | $3.07 |
| Volume (last close) | 3.18M |
| Average Volume (3M) | 2.53M |
| Revenue (TTM) | 35.04M |
|---|---|
| Net Income (TTM) | -101.42M |
| Free Cash Flow (TTM) | -85.39M |
| EPS (TTM) | −$0.91 |
| Profit Margin | -289.44% |
| Operating Margin | -318.97% |
| Return on Equity (ROE) | -41.02% |
| Debt to Equity | 0.23 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 389.48M |
|---|---|
| Shares Outstanding | 130.70M |
| Price to Sales (P/S) | 11.12 |
| Price to Book (P/B) | 1.58 |
| EV/EBITDA | -4.13 |
| 50-Day MA | $3.47 |
|---|---|
| 200-Day MA | $3.17 |
| 1-Year Change | +33.61% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
C4 Therapeutics at a Glance
As of the Oct 26, 2026 close, C4 Therapeutics (CCCC) has a market capitalization of $389.48M. The stock trades at 11.1× sales. Over the trailing twelve months it lost $101.42M on revenue of $35.04M and burned $85.39M of free cash flow. Revenue grew 2.3% year over year.
As of its latest reported balance sheet, it holds $78.61M in cash and securities against $56.86M of debt, a net cash position of $21.75M.
C4 Therapeutics does not currently pay a dividend.
The share price is up 33.6% over the past year. At $2.98 (the Oct 26, 2026 close) it sits within its 52-week range of $1.69 to $5.17, below its 200-day moving average of $3.17.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $8.50, 185.2% above the Oct 26, 2026 close.
Frequently Asked Questions About C4 Therapeutics
What is the current stock price for CCCC?
As of the Oct 26, 2026 close, CCCC stock trades at $2.98. The 52-week range is $1.69–$5.17, with a day range of $2.94–$3.07.
What is the P/E ratio for CCCC?
The P/E ratio (Price-to-Earnings) for CCCC is shown in the Key Statistics section. This valuation metric helps compare C4 Therapeutics, Inc. to industry peers.
Does CCCC pay dividends?
C4 Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CCCC?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for CCCC is Buy. The average 12-month price target is $8.50, a 185.2% upside from the Oct 26, 2026 close of $2.98.
What is the market cap of CCCC?
As of the Oct 26, 2026 close, C4 Therapeutics's market capitalization is $389.5M, classifying it as a small-cap company. C4 Therapeutics operates in the Healthcare sector within the Biotechnology industry.